Stock 1877 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Junshi Biosciences Co., Ltd.

Equities

1877

CNE100003FF7

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:15 2024-04-18 am EDT 		5-day change 1st Jan Change
9.65 HKD -0.62% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. -8.27% -50.36%
Apr. 08 Junshi Biosciences Gets Nod to Register Toripalimab Injection MT
Apr. 07 Shanghai Junshi Biosciences Co., Ltd. Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer CI

Evolution of the average Target Price on Shanghai Junshi Biosciences Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

b62887844fe.qslRdVd6zILeiFLPeYZAQmn3pyeBoJP-DPSR2ZtQLy4.h64cJz8dnPiQ7iuoHqsmMgqw0kK25vGhacLii_0KXEfT5B4QPRyO8ZXtIQ~3106d5c53ed816c1487261e0361d343d

Analyst Recommendations on Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences' 2022 Loss Widens, Misses Analysts' Expectations MT
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy MT
UBS Adjusts Shanghai Junshi Biosciences’ Price Target to HK$70.90 From HK$77.70, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
8.976 CNY
Average target price
22.5 CNY
Spread / Average Target
+150.69%
High Price Target
42.1 CNY
Spread / Highest target
+369.00%
Low Price Target
9.239 CNY
Spread / Lowest Target
+2.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shanghai Junshi Biosciences Co., Ltd.

UBS

Ratings for Shanghai Junshi Biosciences Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. Consensus Shanghai Junshi Biosciences Co., Ltd.